Hansoh Pharmaceutical Group Company Ltd
Hansoh Pharmaceutical Group Waste Data Preview
In 2023, Hansoh Pharmaceutical Group conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
Insights into Hansoh Pharmaceutical Group's Waste Treatment Practices
In 2023, Hansoh Pharmaceutical Group generated a total of 5,237 metric tonnes of waste.
Of this amount, 10.05% of Hansoh Pharmaceutical Group's total waste generated was recovered through methods such as recycling, reuse, or composting, while 0.75% was disposed of through landfilling, incineration, or combustion. The remaining 89.2% was either treated using unspecified methods or not clearly categorized.
Hansoh Pharmaceutical Group's Waste Recovery Rate
How much of Hansoh Pharmaceutical Group's waste is recycled or recovered?
In 2023, Hansoh Pharmaceutical Group reported a total waste generation of 5,237 metric tonnes, of which 10.05% was recovered through recycling, reuse, or composting. This low recovery rate highlights limited waste diversion and suggests that Hansoh Pharmaceutical Group may be relying more heavily on landfill or incineration, underscoring opportunities for stronger resource recovery initiatives.
Has Hansoh Pharmaceutical Group reduced its environmental waste footprint over time?
Since 2021, Hansoh Pharmaceutical Group's total waste generation increased by 9.66%, including a 23.44% increase in 2023, indicating a persistent upward trend that may reflect scaling operations, inefficiencies in resource use, or a lack of effective waste minimization practices.
Over the same period, Hansoh Pharmaceutical Group's waste recovery rate increased by 162.03%, but declined by 13.77% in 2023, potentially signaling volatility in waste treatment processes or shifting priorities in waste management.
Overall, Hansoh Pharmaceutical Group’s waste generation and recovery data show a mixed and inconsistent trend. A deeper analysis of the company's activities, industry benchmarks, and operational changes is needed to assess its sustainability performance more precisely.
Hansoh Pharmaceutical Group’s Waste Recovery vs. Disposal Over Time
- Total Waste Disposed
- Total Waste Recovered
Insights into Hansoh Pharmaceutical Group’s Generation of Hazardous and Non-Hazardous Waste
In 2023, Hansoh Pharmaceutical Group generated a total of 5,237 metric tonnes of waste.
Of this amount, 89.2% of Hansoh Pharmaceutical Group's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 10.8% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
Hansoh Pharmaceutical Group’s Hazardous vs Non-Hazardous Waste Over Time
- Total Non-Hazardous Waste Generated
- Total Hazardous Waste Generated
How Hansoh Pharmaceutical Group reduced the environmental impact of its waste?
Since 2021, Hansoh Pharmaceutical Group's total waste generation increased by 9.66%, including a 23.44% rise in 2023, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems.
Over the same period, the share of hazardous waste remained relatively flat but increased by 3.99% in 2023, which may indicate a recent uptick in high-risk waste production, potentially linked to material sourcing or product mix.
Overall, Hansoh Pharmaceutical Group's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.